Potential myogenic stem cell populations: Sources, plasticity, and application for cardiac repair

Stem Cells and Development

Volumn 18, Issue 6, 2009, Pages 813-829

  Schabort, Elske J ^a   Myburgh, Kathryn H ^a   Wiehe, Juliane M ^b   Torzewski, Jan ^c   Niesler, Carola U ^d  

^a STELLENBOSCH UNIVERSITY   (South Africa)

^b UNIVERSITY OF ULM   (Germany)

^c Cardiovascular Unit   (Germany)

^d UNIVERSITY OF KWAZULU NATAL   (South Africa)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT STEM CELL; ARTICLE; BONE MARROW CELL; CELL DIFFERENTIATION; CELL POPULATION; CELL PROLIFERATION; CELL REGENERATION; CELL RENEWAL; EMBRYONIC STEM CELL; GENE THERAPY; HEART FUNCTION; HEART INFARCTION; HEART MUSCLE CELL; HEMATOPOIETIC STEM CELL; HUMAN; MESENCHYMAL STEM CELL; MULTIPOTENT STEM CELL; MYOBLAST; NONHUMAN; PERICYTE; PLURIPOTENT STEM CELL; PRIORITY JOURNAL; SKELETAL MUSCLE SATELLITE CELL; STEM CELL; STEM CELL TRANSPLANTATION; TISSUE ENGINEERING; TISSUE REPAIR;

ADULT STEM CELLS; ANIMALS; HUMANS; MUSCLE DEVELOPMENT; MYOCARDIUM; REGENERATIVE MEDICINE; STEM CELLS; WOUND HEALING;

ANIMALIA;

EID: 67651122939     PISSN: 15473287     EISSN: None     Source Type: Journal    
DOI: 10.1089/scd.2008.0387     Document Type: Article

References (193)

1. Passier R and C Mummery. (2003). Origin and use of embryonic and adult stem cells in differentiation and tissue repair. Cardiovasc Res 58:324-335.
2. Smith C, MJ Kruger, RM Smith and KH Myburgh. (2008). The inf ammatory response to skeletal muscle injury: illuminating complexities. Sports Med 38:947-969.
3. Anversa P, A Leri, M Rota, T Hosoda, C Bearzi, K Urbanek, J Kajstura and R Bolli. (2007). Concise review: stem cells, myo-cardial regeneration, and methodological artifacts. Stem Cells 25:589-601.
4. Lakshmipathy U and C Verfaillie. (2005). Stem cell plasticity. Blood Rev 19:29-38.
5. Hawke TJ and DJ Garry. (2001). Myogenic satellite cells: physiology to molecular biology. J Appl Physiol 91:534-551.
6. Pittenger MF and BJ Martin. (2004). Mesenchymal stem cells and their potential as cardiac therapeutics. Circ Res 95:9-20.
7. Itskovitz-Eldor J, M Schuldiner, D Karsenti, A Eden, O Yanuka, M Amit, H Soreq and N Benvenisty. (2000). Differentiation of human embryonic stem cells into embryoid bodies compromising the three embryonic germ layers. Mol Med 6:88-95.
8. Thomson JA, J Itskovitz-Eldor, SS Shapiro, MA Waknitz, JJ Swiergiel, VS Marshall and JM Jones. (1998). Embryonic stem cell lines derived from human blastocysts. Science 282:1145-1147.
9. Wobus AM and KR Boheler. (2005). Embryonic stem cells: prospects for developmental biology and cell therapy. Physiol Rev 85:635-678.
10. Seraf ni M and CM Verfaillie. (2006). Pluripotency in adult stem cells: state of the art. Semin Reprod Med 24:379-388.
11. Mays RW, W van't Hof, AE Ting, R Perry and R Deans. (2007). Development of adult pluripotent stem cell therapies for ische-mic injury and disease. Expert Opin Biol Ther 7:173-184.
12. Broxmeyer HE, GW Douglas, G Hangoc, S Cooper, J Bard, D English, M Arny, L Thomas and EA Boyse. (1989). Human umbilical cord blood as a potential source of transplantable hematopoietic stem/progenitor cells. Proc Natl Acad Sci USA 86:3828-3832.
13. Deans RJ and AB Moseley. (2000). Mesenchymal stem cells: biology and potential clinical uses. Exp Hematol 28:875-884.
14. Zuk PA, M Zhu, P Ashjian, DA De Ugarte, JI Huang, H Mizuno, ZC Alfonso, JK Fraser, P Benhaim and MH Hedrick. (2002). Human adipose tissue is a source of multipotent stem cells. Mol Biol Cell 13:4279-4295.
15. Bieback K, S Kern, H Kluter and H Eichler. (2004). Critical parameters for the isolation of mesenchymal stem cells from umbilical cord blood. Stem Cells 22:625-634.
16. Tuan RS, G Boland and R Tuli. (2003). Adult mesenchymal stem cells and cell-based tissue engineering. Arthritis Res Ther 5:32-45.
17. Reyes M and CM Verfaillie. (2001). Characterization of multi-potent adult progenitor cells, a subpopulation of mesenchymal stem cells. Ann N Y Acad Sci 938:231-233; discussion 233-235.
18. Jiang Y, B Vaessen, T Lenvik, M Blackstad, M Reyes and CM Verfaillie. (2002). Multipotent progenitor cells can be isolated from postnatal murine bone marrow, muscle, and brain. Exp Hematol 30:896-904.
19. Gussoni E, Y Soneoka, CD Strickland, EA Buzney, MK Khan, AF Flint, LM Kunkel and RC Mulligan. (1999). Dystrophin expression in the mdx mouse restored by stem cell transplantation. Nature 401:390-394.
20. LaBarge MA and HM Blau. (2002). Biological progression from adult bone marrow to mononucleate muscle stem cell to multinucleate muscle f ber in response to injury. Cell 111:589-601.
21. Dreyfus PA, F Chretien, B Chazaud, Y Kirova, P Caramelle, L Garcia, G Butler-Browne and RK Gherardi. (2004). Adult bone marrow-derived stem cells in muscle connective tissue and satellite cell niches. Am J Pathol 164:773-779.
22. Wernig G, V Janzen, R Schafer, M Zweyer, U Knauf, O Hoegemeier, RR Mundegar, S Garbe, S Stier, T Franz, M Wernig and A Wernig. (2005). The vast majority of bone-marrow-derived cells integrated into mdx muscle f bers are silent despite long-term engraftment. Proc Natl Acad Sci USA 102:11852-11857.
23. Ratajczak MZ, E Zuba-Surma, M Kucia, R Reca, W Wojakowski and J Ratajczak. (2006). The pleiotropic effects of the SDF-1-CXCR4 axis in organogenesis, regeneration and tumorigene-sis. Leukemia 20:1915-1924.
24. Kucia M, R Reca, FR Campbell, E Zuba-Surma, M Majka, J Ratajczak and MZ Ratajczak. (2006). A population of very small embryonic-like (VSEL) CXCR4(+)SSEA-1(+)Oct-4+ stem cells identif ed in adult bone marrow. Leukemia 20:857-869.
25. Terada N, T Hamazaki, M Oka, M Hoki, DM Mastalerz, Y Nakano, EM Meyer, L Morel, BE Petersen and EW Scott. (2002). Bone marrow cells adopt the phenotype of other cells by spontaneous cell fusion. Nature 416:542-545.
26. Kucia M, J Ratajczak and MZ Ratajczak. (2005). Bone marrow a s a source of ci rc u lat i ng CXCR4+ t issue- com m itted stem cell s. Biol Cell 97:133-146.
27. Ratajczak MZ, M Kucia, M Majka, R Reca and J Ratajczak. (2004). Heterogeneous populations of bone marrow stem cells - are we spotting on the same cells from the different angles? Folia Histochem Cytobiol 42:139-146.
28. Dawn B and R Bolli. (2005). Bone marrow cells for cardiac regeneration: the quest for the protagonist continues. Cardiovasc Res 65:293-295.
29. Asahara T, H Masuda, T Takahashi, C Kalka, C Pastore, M Silver, M Kearne, M Magner and JM Isner. (1999). Bone marrow origin of endothelial progenitor cells responsible for postnatal vasculogenesis in physiological and pathological neovascular-ization. Circ Res 85:221-228.
30. Murohara T, H Ikeda, J Duan, S Shintani, K Sasaki, H Eguchi, I Onitsuka, K Matsui and T Imaizumi. (2000). Transplanted cord blood-derived endothelial precursor cells augment postnatal neovascularization. J Clin Invest 105:1527-1536.
31. Pelton RW, B Saxena, M Jones, HL Moses and LI Gold. (1991). Immunohistochemical localization of TGF beta 1, TGF beta 2, and TGF beta 3 in the mouse embryo: expression patterns suggest multiple roles during embryonic development. J Cell Biol 115:1091-1105.
32. Pelosi E, M Valtieri, S Coppola, R Botta, M Gabbianelli, V Lulli, G Marziali, B Masella, R Muller, C Sgadari, U Testa, G Bonanno and C Peschle. (2002). Identif cation of the hemangioblast in postnatal life. Blood 100:3203-3208.
33. Bailey AS and WH Fleming. (2003). Converging roads: evidence for an adult hemangioblast. Exp Hematol 31:987-993.
34. Forrai A and L Robb. (2003). The hemangioblast - between blood and vessels. Cell Cycle 2:86-90.
35. Crisan M, B Deasy, M Gavina, B Zheng, J Huard, L Lazzari and B Peault. (2008). Purif cation and long-term culture of multipo-tent progenitor cells aff liated with the walls of human blood vessels: myoendothelial cells and pericytes. Methods Cell Biol 86:295-309.
36. Crisan M, S Yap, L Casteilla, CW Chen, M Corselli, TS Park, G Andriolo, B Sun, B Zheng, L Zhang, C Norotte, PN Teng, J Traas, R Schugar, BM Deasy, S Badylak, HJ Buhring, JP Giacobino, L Lazzari, J Huard and B Peault. (2008). A perivas-cular origin for mesenchymal stem cells in multiple human organs. Cell Stem Cell 3:301-313.
37. Crisan M, J Huard, B Zheng, B Sun, S Yap, A Logar, JP Giacobino, L Casteilla and B Peault. (2008). Purif cation and culture of human blood vessel-associated progenitor cells. Curr Protoc Stem Cell Biol Chapter 2:Unit 2B 21-2B 213.
38. Kogler G, S Sensken, JA Airey, T Trapp, M Muschen, N Feldhahn, S Liedtke, RV Sorg, J Fischer, C Rosenbaum, S Greschat, A Knipper, J Bender, O Degistirici, J Gao, AI Caplan, EJ Colletti, G Almeida-Porada, HW Muller, E Zanjani and P Wernet. (2004). A new human somatic stem cell from placental cord blood with intrinsic pluripotent differentiation potential. J Exp Med 200:123-135.
39. Koblas T, SM Harman and F Saudek. (2005). The application of umbilical cord blood cells in the treatment of diabetes melli-tus. Rev Diabet Stud 2:228-234.
40. McGuckin CP, D Pearce, N Forraz, JA Tooze, SM Watt and R Pettengell. (2003). Multiparametric analysis of immature cell populations in umbilical cord blood and bone marrow. Eur J Haematol 71:341-350.
41. Zhao Y, H Wang and T Mazzone. (2006). Identif cation of stem cells from human umbilical cord blood with embryonic and hematopoietic characteristics. Exp Cell Res 312:2454-2464.
42. McGuckin C P, N Forraz, Q Allouard and R Pettengell. (2004). Umbilical cord blood stem cells can expand hematopoietic and neuroglial progenitors in vitro. Exp Cell Res 295:350-359.
43. Urbanek K, D Cesselli, M Rota, A Nascimbene, A De Angelis, T Hosoda, C Bearzi, A Boni, R Bolli, J Kajstura, P Anversa and A Leri. (2006). Stem cell niches in the adult mouse heart. Proc Natl Acad Sci USA 103:9226-9231.
44. Zuk PA, M Zhu, H Mizuno, J Huang, JW Futrell, AJ Katz, P Benhaim, HP Lorenz and MH Hedrick. (2001). Multilineage cells from human adipose tissue: implications for cell-based therapies. Tissue Eng 7:211-228.
45. Malouf NN, WB Coleman, JW Grisham, RA Lininger, VJ Madden, M Sproul and PA Anderson. (2001). Adult-derived stem cells from the liver become myocytes in the heart in vivo. Am J Pathol 158:1929-1935.
46. Grounds MD, JD White, N Rosenthal and MA Bogoyevitch. (2002). The role of stem cells in skeletal and cardiac muscle repair. J Histochem Cytochem 50:589-610.
47. Cossu G, P Cicinelli, C Fieri, M Coletta and M Molinaro. (1985). Emergence of TPA-resistant "satellite" cells during muscle his-togenesis of human limb. Exp Cell Res 160:403-411.
48. Schultz E and KM McCormick. (1994). Skeletal muscle satellite cells. Rev Physiol Biochem Pharmacol 123:213-257.
49. Rosenblatt JD, DJ Parry and TA Partridge. (1996). Phenotype of adult mouse muscle myoblasts ref ects their f ber type of origin. Differentiation 60:39-45.
50. Partridge T. (2004). Reenthronement of the muscle satellite cell. Cell 119:447-448.
51. Velloso CP, A Kumar, EM Tanaka and JP Brockes. (2000). Generation of mononucleate cells from post-mitotic myo-tubes proceeds in the absence of cell cycle progression. Differentiation 66:239-246.
52. Cornelison DD and BJ Wold. (1997). Single-cell analysis of regulatory gene expression in quiescent and activated mouse skeletal muscle satellite cells. Dev Biol 191:270-283.
53. Zammit PS, TA Partridge and Z Yablonka-Reuveni. (2006). The skeletal muscle satellite cell: the stem cell that came in from the cold. J Histochem Cytochem 54:1177-1191.
54. Beauchamp JR, L Heslop, DS Yu, S Tajbakhsh, RG Kelly, A Wernig, ME Buckingham, TA Partridge and PS Zammit. (2000). Expression of CD34 and Myf5 def nes the majority of quiescent adult skeletal muscle satellite cells. J Cell Biol 151:1221-1234.
55. Charge SB and MA Rudnicki. (2004). Cellular and molecular regulation of muscle regeneration. Physiol Rev 84:209-238.
56. Schultz E. (1996). Satellite cell proliferative compartments in growing skeletal muscles. Dev Biol 175:84-94.
57. McCroskery S, M Thomas, L Maxwell, M Sharma and R Kambadur. (2003). Myostatin negatively regulates satellite cell activation and self-renewal. J Cell Biol 162:1135-1147.
58. Cornelison DD, MS Filla, HM Stanley, AC Rapraeger and BB Olwin. (2001). Syndecan-3 and syndecan-4 specif cally mark skeletal muscle satellite cells and are implicated in satellite cell maintenance and muscle regeneration. Dev Biol 239:79-94.
59. Cornelison DD, SA Wilcox-Adelman, PF Goetinck, H Rauvala, AC Rapraeger and BB Olwin. (2004). Essential and separable roles for Syndecan-3 and Syndecan-4 in skeletal muscle development and regeneration. Genes Dev 18:2231-2236.
60. Jankowski RJ, BM Deasy and J Huard. (2002). Muscle-derived stem cells. Gene Ther 9:642-647.
61. Nagata Y, H Kobayashi, M Umeda, N Ohta, S Kawashima, PS Zammit and R Matsuda. (2006). Sphingomyelin levels in the plasma membrane correlate with the activation state of muscle satellite cells. J Histochem Cytochem 54:375-384.
62. Fukada S, S Higuchi, M Segawa, K Koda, Y Yamamoto, K Tsujikawa, Y Kohama, A Uezumi, M Imamura, Y Miyagoe-Suzuki, S Takeda and H Yamamoto. (2004). Purif cation and cell-surface marker characterization of quiescent satellite cells from murine skeletal muscle by a novel monoclonal antibody. Exp Cell Res 296:245-255.
63. Volonte D, Y Liu and F Galbiati. (2005). The modulation of caveolin-1 expression controls satellite cell activation during muscle repair. FASEB J 19:237-239.
64. Ferrari G, G Cusella-De Angelis, M Coletta, E Paolucci, A Stornaiuolo, G Cossu and F Mavilio. (1998). Muscle regeneration by bone marrow-derived myogenic progenitors. Science 279:1528-1530.
65. Asakura A, P Seale, A Girgis-Gabardo and MA Rudnicki. (2002). Myogenic specif cation of side population cells in skeletal muscle. J Cell Biol 159:123-134.
66. Tamaki T, A Akatsuka, K Ando, Y Nakamura, H Matsuzawa, T Hotta, RR Roy and VR Edgerton. (2002). Identif cation of myo-genic-endothelial progenitor cells in the interstitial spaces of skeletal muscle. J Cell Biol 157:571-577.
67. Qu-Petersen Z, B Deasy, R Jankowski, M Ikezawa, J Cummins, R Pruchnic, J Mytinger, B Cao, C Gates, A Wernig and J Huard. (2002). Identif cation of a novel population of muscle stem cells in mice: potential for muscle regeneration. J Cell Biol 157:851-864.
68. Zheng B, B Cao, M Crisan, B Sun, G Li, A Logar, S Yap, JB Pollett, L Drowley, T Cassino, B Gharaibeh, BM Deasy, J Huard and B Peault. (2007). Prospective identif cation of myogenic endothelial cells in human skeletal muscle. Nat Biotechnol 25:1025-1034.
69. Gharaibeh B, A Lu, J Tebbets, B Zheng, J Feduska, M Crisan, B Peault, J Cummins and J Huard. (2008). Isolation of a slowly adhering cell fraction containing stem cells from murine skeletal muscle by the preplate technique. Nat Protoc 3:1501-1509.
70. Asakura A and MA Rudnicki. (2002). Side population cells from diverse adult tissues are capable of in vitro hematopoi-etic differentiation. Exp Hematol 30:1339-1345.
71. Alessandri G, S Pagano, A Bez, A Benetti, S Pozzi, G Iannolo, M Baronio, G Invernici, A Caruso, C Muneretto, G Bisleri and E Parati. (2004). Isolation and culture of human muscle-derived stem cells able to differentiate into myogenic and neurogenic cell lineages. Lancet 364:1872-1883.
72. Okada M, TR Payne, B Zheng, H Oshima, N Momoi, K Tobita, BB Keller, JA Phillippi, B Peault and J Huard. (2008). Myogenic endothelial cells purif e d f r o m h u m a n s k e l e t a l m u s c l e i m p r o v e cardiac function after transplantation into infarcted myocardium. J Am Coll Cardiol 52:1869-1880.
73. Baroff o A, M Hamann, L Bernheim, ML Bochaton-Piallat, G Gabbiani and CR Bader. (1996). Identif cation of self-renewing myoblasts in the progeny of single human muscle satellite cells. Differentiation 60:47-57.
74. Quaini F, K Urbanek, AP Beltrami, N Finato, CA Beltrami, B Nadal-Ginard, J Kajstura, A Leri and P Anversa. (2002). Chimerism of the transplanted heart. N Engl J Med 346:5-15.
75. Laf amme MA, D Myerson, JE Saff tz and CE Murry. (2002). Evidence for cardiomyocyte repopulation by extracardiac progenitors in transplanted human hearts. Circ Res 90:634-640.
76. Beltrami A P, L Barlucchi, D Torella, M Baker, F Limana, S Chimenti, H Kasahara, M Rota, E Musso, K Urbanek, A Leri, J Kajstura, B Nadal-Ginard and P Anversa. (2003). Adult cardiac stem cells are multipotent and support myocardial regeneration. Cell 114:763-776.
77. Oh H, X Chi, SB Bradfute, Y Mishina, J Pocius, LH Michael, RR Behringer, RJ Schwartz, ML Entman and MD Schneider. (2004). Cardiac muscle plasticity in adult and embryo by heart-derived progenitor cells. Ann N Y Acad Sci 1015:182-189.
78. Laugwitz KL, A Moretti, J Lam, P Gruber, Y Chen, S Woodard, LZ Lin, CL Cai, MM Lu, M Reth, O Platoshyn, JX Yuan, S Evans and KR Chien. (2005). Postnatal isl1+ cardioblasts enter fully differentiated cardiomyocyte lineages. Nature 433:647-653.
79. Urbanek K, F Quaini, G Tasca, D Torella, C Castaldo, B Nadal-Ginard, A Leri, J Kajstura, E Quaini and P Anversa. (2003). Intense myocyte formation from cardiac stem cells in human cardiac hypertrophy. Proc Natl Acad Sci USA 100:10440-10445.
80. Hierlihy AM, P Seale, CG Lobe, MA Rudnicki and LA Megeney. (2002). The post-natal heart contains a myocardial stem cell population. FEBS Lett 530:239-243.
81. Martin CM, AP Meeson, SM Robertson, TJ Hawke, JA Richardson, S Bates, SC Goetsch, TD Gallardo and DJ Garry. (2004). Persistent expression of the ATP-binding cassette transporter, Abcg2, identif es cardiac SP cells in the developing and adult heart. Dev Biol 265:262-275.
82. Pf ster O, F Mouquet, M Jain, R Summer, M Helmes, A Fine, WS Colucci and R Liao. (2005). CD31- but Not CD31+ cardiac side population cells exhibit functional cardiomyogenic differentiation. Circ Res 97:52-61.
83. Ott HC, TS Matthiesen, J Brechtken, S Grindle, SK Goh, W Nelson and DA Taylor. (2007). The adult human heart as a source for stem cells: repair strategies with embryonic-like progenitor cells. Nat Clin Pract Cardiovasc Med 4(Suppl 1):S27-S39.
84. Yoon YS, A Wecker, L Heyd, JS Park, T Tkebuchava, K Kusano, A Hanley, H Scadova, G Qin, DH Cha, KL Johnson, R Aikawa, T Asahara and DW Losordo. (2005). Clonally expanded novel multipotent stem cells from human bone marrow regenerate myocardium after myocardial infarction. J Clin Invest 115:326-338.
85. Kues WA, B Petersen, W Mysegades, JW Carnwath and H Niemann. (2005). Isolation of murine and porcine fetal stem cells from somatic tissue. Biol Reprod 72:1020-1028.
86. D'Ippolito G, S Diabira, GA Howard, P Menei, BA Roos and PC Schiller. (2004). Marrow-isolated adult multilineage inducible (MIAMI) cells, a unique population of postnatal young and old human cells with extensive expansion and differentiation potential. J Cell Sci 117:2971-2981.
87. Toma JG, M Akhavan, KJ Fernandes, F Barnabe-Heider, A Sadikot, DR Kaplan and FD Miller. (2001). Isolation of multipo-tent adult stem cells from the dermis of mammalian skin. Nat Cell Biol 3:778-784.
88. Lin H. (1997). The tao of stem cells in the germline. Annu Rev Genet 31:455-491.
89. Wagers AJ and IL Weissman. (2004). Plasticity of adult stem cells. Cell 116:639-648.
90. Moraleda JM, M Blanquer, P Bleda, P Iniesta, F Ruiz, S Bonilla, C Cabanes, L Tabares and S Martinez. (2006). Adult stem cell therapy: dream or reality? Transpl Immunol 17:74-77.
91. Jiang Y, BN Jahagirdar, RL Reinhardt, RE Schwartz, CD Keene, XR Ortiz-Gonzalez, M Reyes, T Lenvik, T Lund, M Blackstad, J Du, S Aldrich, A Lisberg, WC Low, DA Largaespada and CM Verfaillie. (2002). Pluripotency of mesenchymal stem cells derived from adult marrow. Nature 418:41-49.
92. Devine SM, C Cobbs, M Jennings, A Bartholomew and R Hoffman. (2003). Mesenchymal stem cells distribute to a wide range of tissues following systemic infusion into nonhuman primates. Blood 101:2999-3001.
93. Goodell MA. (2003). Stem-cell "plasticity": befuddled by the muddle. Curr Opin Hematol 10:208-213.
94. Zipori D. (2005). The stem state: plasticity is essential, whereas self-renewal and hierarchy are optional. Stem Cells 23:719-726.
95. Choi JB, H Uchino, K Azuma, N Iwashita, Y Tanaka, H Mochizuki, M Migita, T Shimada, R Kawamori and H Watada. (2003). Little evidence of transdifferentiation of bone marrow-derived cells into pancreatic beta cells. Diabetologia 46:1366-1374.
96. Ono K, K Yoshihara, H Suzuki, KF Tanaka, T Takii, K Onozaki and M Sawada. (2003). Preservation of hematopoietic properties in transplanted bone marrow cells in the brain. J Neurosci Res 72:503-507.
97. Vallieres L and PE Sawchenko. (2003). Bone marrow-derived cells that populate the adult mouse brain preserve their hematopoietic identity. J Neurosci 23:5197-5207.
98. Orlic D, J Kajstura, S Chimenti, DM Bodine, A Leri and P Anversa. (2001). Transplanted adult bone marrow cells repair myocardial infarcts in mice. Ann N Y Acad Sci 938:221-229; discussion 229-230.
99. Leri A, J Kajstura and P Anversa. (2005). Identity deception: not a crime for a stem cell. Physiology (Bethesda) 20:162-168.
100. Murry CE, MH Soonpaa, H Reinecke, H Nakajima, HO Nakajima, M Rubart, KB Pasumarthi, JI Virag, SH Bartelmez, V Poppa, G Bradford, JD Dowell, DA Williams and LJ Field. (2004). Haematopoietic stem cells do not transdifferentiate into cardiac myocytes in myocardial infarcts. Nature 428:664-668.
101. Nygren JM, S Jovinge, M Breitbach, P Sawen, W Roll, J Hescheler, J Taneera, BK Fleischmann and SE Jacobsen. (2004). Bone marrow-derived hematopoietic cells generate cardio-myocytes at a low frequency through cell fusion, but not trans-differentiation. Nat Med 10:494-501.
102. Hawley RG and DA Sobieski. (2002). Somatic stem cell plasticity: to be or not to be. Stem Cells 20:195-197.
103. Holden C and G Vogel. (2002). Stem cells. Plasticity: time for a reappraisal? Science 296:2126-2129.
104. Lemischka I. (2002). Rethinking somatic stem cell plasticity. Nat Biotechnol 20:425.
105. Verfaillie CM, MF Pera and PM Lansdorp. (2002). Stem cells: hype and reality. Hematology Am Soc Hematol Educ Program 1:369-391.
106. Ying QL, J Nichols, EP Evans and AG Smith. (2002). Changing potency by spontaneous fusion. Nature 416:545-548.
107. Wilmut I, AE Schnieke, J McWhir, AJ Kind and KH Campbell. (1997). Viable offspring derived from fetal and adult mammalian cells. Nature 385:810-813.
108. Bischoff R and C Heintz. (1994). Enhancement of skeletal muscle regeneration. Dev Dyn 201:41-54.
109. Asakura A, M Komaki and M Rudnicki. (2001). Muscle satellite cells are multipotential stem cells that exhibit myogenic, osteo-genic, and adipogenic differentiation. Differentiation 68:245-253.
110. Wada MR, M Inagawa-Ogashiwa, S Shimizu, S Yasumoto and N Hashimoto. (2002). Generation of different fates from multi-potent muscle stem cells. Development 129:2987-2995.
111. Price FD, K Kuroda and MA Rudnicki. (2007). Stem cell based therapies to treat muscular dystrophy. Biochim Biophys Acta 1772:272-283.
112. Bittner RE, C Schofer, K Weipoltshammer, S Ivanova, B Streubel, E Hauser, M Freilinger, H Hoger, A Elbe-Burger and F Wachtler. (1999). Recruitment of bone-marrow-derived cells by skeletal and cardiac muscle in adult dystrophic mdx mice. Anat Embryol (Berl) 199:391-396.
113. Gussoni E, RR Bennett, KR Muskiewicz, T Meyerrose, JA Nolta, I Gilgoff, J Stein, YM Chan, HG Lidov, CG Bonnemann, A Von Moers, GE Morris, JT Den Dunnen, JS Chamberlain, LM Kunkel and K Weinberg. (2002). Long-term persistence of donor nuclei in a Duchenne muscular dystrophy patient receiving bone marrow transplantation. J Clin Invest 110:807-814.
114. Zammit P and J Beauchamp. (2001). The skeletal muscle satellite cell: stem cell or son of stem cell? Differentiation 68:193-204.
115. Clarke DL, CB Johansson, J Wilbertz, B Veress, E Nilsson, H Karlstrom, U Lendahl and J Frisen. (2000). Generalized potential of adult neural stem cells. Science 288:1660-1663.
116. Galli R, U Borello, A Gritti, MG Minasi, C Bjornson, M Coletta, M Mora, MG De Angelis, R Fiocco, G Cossu and AL Vescovi. (2000). Skeletal myogenic potential of human and mouse neural stem cells. Nat Neurosci 3:986-991.
117. Di Rocco G, MG Iachininoto, A Tritarelli, S Straino, A Zacheo, A Germani, F Crea and MC Capogrossi. (2006). Myogenic potential of adipose-tissue-derived cells. J Cell Sci 119:2945-2952.
118. Beauchamp JR, JE Morgan, CN Pagel and TA Partridge. (1999). Dynamics of myoblast transplantation reveal a discrete minority of precursors with stem cell-like properties as the myogenic source. J Cell Biol 144:1113-1122.
119. Smythe GM, SI Hodgetts and MD Grounds. (2001). Problems and solutions in myoblast transfer therapy. J Cell Mol Med 5:33-47.
120. Azarnoush K, A Maurel, L Sebbah, C Carrion, A Bissery, C Mandet, J Pouly, P Bruneval, AA Hagege and P Menasche. (2005). Enhancement of the functional benef ts of skeletal myo-blast transplantation by means of coadministration of hypoxia-inducible factor 1alpha. J Thorac Cardiovasc Surg 130:173-179.
121. Montarras D, J Morgan, C Collins, F Relaix, S Zaffran, A Cumano, T Partridge and M Buckingham. (2005). Direct isolation of satellite cells for skeletal muscle regeneration. Science 309:2064-2067.
122. Smythe GM and MD Grounds. (2001). Absence of MyoD increases donor myoblast migration into host muscle. Exp Cell Res 267:267-274.
123. Dawn B and R Bolli. (2005). Cardiac progenitor cells: the revolution continues. Circ Res 97:1080-1082.
124. Messina E, L De Angelis, G Frati, S Morrone, S Chimenti, F Fiordaliso, M Salio, M Battaglia, MV Latronico, M Coletta, E Vivarelli, L Frati, G Cossu and A Giacomello. (2004). Isolation and expansion of adult cardiac stem cells from human and murine heart. Circ Res 95:911-921.
125. Bucala R, LA Spiegel, J Chesney, M Hogan and A Cerami. (1994). Circulating f brocytes def ne a new leukocyte subpopu-lation that mediates tissue repair. Mol Med 1:71-81.
126. Barile L, I Chimenti, R Gaetani, E Forte, F Miraldi, G Frati, E Messina and A Giacomello. (2007). Cardiac stem cells: isolation, expansion and experimental use for myocardial regeneration. Nat Clin Pract Cardiovasc Med 4(Suppl 1):S9-S14.
127. Jackson KA, SM Majka, H Wang, J Pocius, CJ Hartley, MW Majesky, ML Entman, LH Michael, KK Hirschi and MA Goodell. (2001). Regeneration of ischemic cardiac muscle and vascular endothelium by adult stem cells. J Clin Invest 107:1395-1402.
128. Anversa P and B Nadal-Ginard. (2002). Myocyte renewal and ventricular remodelling. Nature 415:240-243.
129. Kucia M, J Ratajczak, R Reca, A Janowska-Wieczorek and MZ Ratajczak. (2004). Tissue-specif c muscle, neural and liver stem/progenitor cells reside in the bone marrow, respond to an SDF-1 gradient and are mobilized into peripheral blood during stress and tissue injury. Blood Cells Mol Dis 32:52-57.
130. Orlic D, J Kajstura, S Chimenti, F Limana, I Jakoniuk, F Quaini, B Nadal-Ginard, DM Bodine, A Leri and P Anversa. (2001). Mobilized bone marrow cells repair the infarcted heart, improving function and survival. Proc Natl Acad Sci USA 98:10344-10349.
131. Wollert KC and H Drexler. (2005). Clinical applications of stem cells for the heart. Circ Res 96:151-163.
132. Wiehe JM, C Niesler, J Torzewski, O Zimmermann, M Wiesneth, M Schmitt, K Schwarz, H Dohner, V Hombach and J Greiner. (2006). Eff cient transient genetic labeling of human CD34+ progenitor cells for in vivo application. Regen Med 1:223-234.
133. Forrester JS, MJ Price and RR Makkar. (2003). Stem cell repair of infarcted myocardium: an overview for clinicians. Circulation 108:1139-1145.
134. Menasche P. (2003). Cell transplantation in myocardium. Ann Thorac Surg 75:S20-S28.
135. Goodell MA, KA Jackson, SM Majka, T Mi, H Wang, J Pocius, CJ Hartley, MW Majesky, ML Entman, LH Michael and KK Hirschi. (2001). Stem cell plasticity in muscle and bone marrow. Ann N Y Acad Sci 938:208-218; discussion 218-220.
136. Toma C, MF Pittenger, KS Cahill, BJ Byrne and PD Kessler. (2002). Human mesenchymal stem cells differentiate to a car-diomyocyte phenotype in the adult murine heart. Circulation 105:93-98.
137. Kajstura J, M Rota, B Whang, S Cascapera, T Hosoda, C Bearzi, D Nurzynska, H Kasahara, E Zias, M Bonafe, B Nadal-Ginard, D Torella, A Nascimbene, F Quaini, K Urbanek, A Leri and P Anversa. (2005). Bone marrow cells differentiate in cardiac cell lineages after infarction independently of cell fusion. Circ Res 96:127-137.
138. Kuethe F, BM Richartz, HG Sayer, C Kasper, GS Werner, K Hoffken and HR Figulla. (2004). Lack of regeneration of myocardium by autologous intracoronary mononuclear bone marrow cell transplantation in humans with large anterior myocardial infarctions. Int J Cardiol 97:123-127.
139. Davani S, F Deschaseaux, D Chalmers, P Tiberghien and JP Kantelip. (2005). Can stem cells mend a broken heart? Cardiovasc Res 65:305-316.
140. Strauer BE, M Brehm, T Zeus, M Kostering, A Hernandez, RV Sorg, G Kogler and P Wernet. (2002). Repair of infarcted myocardium by autologous intracoronary mononuclear bone marrow cell transplantation in humans. Circulation 106:1913-1918.
141. Schachinger V, B Assmus, MB Britten, J Honold, R Lehmann, C Teupe, ND Abolmaali, TJ Vogl, WK Hofmann, H Martin, S Dimmeler and AM Zeiher. (2004). Transplantation of progenitor cells and regeneration enhancement in acute myocardial infarction: f nal one-year results of the TOPCARE-AMI Trial. J Am Coll Cardiol 44:1690-1699.
142. Schachinger V, B Assmus, J Honold, R Lehmann, WK Hofmann, H Martin, S Dimmeler and AM Zeiher. (2006). Normalization of coronary blood f ow in the infarct-related artery after intra-coronary progenitor cell therapy: intracoronary Doppler sub-study of the TOPCARE-AMI trial. Clin Res Cardiol 95:13-22.
143. Meyer G P, KC Wollert, J Lotz, J Steffens, P Lippolt, S Fichtner, H Hecker, A Schaefer, L Arseniev, B Hertenstein, A Ganser and H Drexler. (2006). Intracoronary bone marrow cell transfer after myocardial infarction: eighteen months' follow-up data from the randomized, controlled BOOST (BOne marrOw transfer to enhance ST-elevation infarct regeneration) trial. Circulation 113:1287-1294.
144. Wollert KC, GP Meyer, J Lotz, S Ringes-Lichtenberg, P Lippolt, C Breidenbach, S Fichtner, T Korte, B Hornig, D Messinger, L Arseniev, B Hertenstein, A Ganser and H Drexler. (2004). Intracoronary autologous bone-marrow cell transfer after myocardial infarction: the BOOST randomised controlled clinic altrial. Lancet 364:141-148.
145. Engelmann MG, HD Theiss, C Hennig-Theiss, A Huber, BJ Wintersperger, AE Werle-Ruedinger, SO Schoenberg, G Steinbeck and WM Franz. (2006). Autologous bone marrow stem cell mobilization induced by granulocyte colony-stimulating factor after subacute ST-segment elevation myocardial infarctionu ndergoing late revascularization: final results from the G-CSF-STEMI (Granulocyte Colony-Stimulating Factor ST-Segment Elevation Myocardial Infarction) trial. J Am Coll Cardiol 48:1712-1721.
146. Assmus B, V Schachinger, C Teupe, M Britten, R Lehmann, N Dobert, F Grunwald, A Aicher, C Urbich, H Martin, D Hoelzer, S Dimmeler and AM Zeiher. (2002). Transplantation of progenitor cells and regeneration enhancement in acute myocardial infarction (TOPCARE-AMI). Circulation 106:3009-3017.
147. Zohlnhofer D, A Kastrati and A Schomig. (2007). Stem cell mobilization by granulocyte-colony-stimulating factor in acute myocardial infarction: lessons from the REVIVAL-2 trial. Nat Clin Pract Cardiovasc Med 4(Suppl 1):S106-S109.
148. Kang HJ, HS Kim, BK Koo, YJ Kim, D Lee, DW Sohn, BH Oh and YB Park. (2007). Intracoronary infusion of the mobilized peripheral blood stem cell by G-CSF is better than mobilization alone by G-CSF for improvement of cardiac function and remodeling: 2-year follow-up results of the Myocardial Regeneration and Angiogenesis in Myocardial Infarction with G-CSF and Intra-Coronary Stem Cell Infusion (MAGIC Cell) 1 trial. Am Heart J 153:237 e231-e238.
149. Kang HJ, HS Kim, SY Zhang, KW Park, HJ Cho, BK Koo, YJ Kim, D Soo Lee, DW Sohn, KS Han, BH Oh, MM Lee and YB Park. (2004). Effects of intracoronary infusion of peripheral blood stem-cells mobilised with granulocyte-colony stimulating factor on left ventricular systolic function and restenosis after coronary stenting in myocardial infarction: the MAGIC cell randomised clinical trial. Lancet 363:751-756.
150. Kocher AA, MD Schuster, MJ Szabolcs, S Takuma, D Burkhoff, J Wang, S Homma, NM Edwards and S Itescu. (2001). Neovascularization of ischemic myocardium by human bone-marrow-derived angioblasts prevents cardiomyocyte apopto-sis, reduces remodeling and improves cardiac function. Nat Med 7:430-436.
151. Martin-Rendon E, S Brunskill, C Doree, C Hyde, S Watt, A Mathur and S Stanworth. (2008). Stem cell treatment for acute myocardial infarction. Cochrane Database Syst Rev:CD006536.
152. Hutcheson KA, BZ Atkins, MT Hueman, MB Hopkins, DD Glower and DA Taylor. (2000). Comparison of benef ts on myo-cardial performance of cellular cardiomyoplasty with skeletal myoblasts and f broblasts. Cell Transplant 9:359-368.
153. Sakai T, RK Li, RD Weisel, DA Mickle, ZQ Jia, S Tomita, EJ Kim and TM Yau. (1999). Fetal cell transplantation: a comparison of three cell types. J Thorac Cardiovasc Surg 118:715-724.
154. Kim EJ, RK Li, RD Weisel, DA Mickle, ZQ Jia, S Tomita, T Sakai and TM Yau. (2001). Angiogenesis by endothelial cell transplantation. J Thorac Cardiovasc Surg 122:963-971.
155. Scorsin M, A Hagege, JT Vilquin, M Fiszman, F Marotte, JL Samuel, L Rappaport, K Schwartz and P Menasche. (2000). Comparison of the effects of fetal cardiomyocyte and skeletal myoblast transplantation on postinfarction left ventricular function. J Thorac Cardiovasc Surg 119:1169-1175.
156. Muller-Ehmsen J, LH Kedes, RH Schwinger and RA Kloner. (2002). Cellular
157. Ruhparwar A, J Tebbenjohanns, M Niehaus, M Mengel, T Irtel, T Kof dis, AM Pichlmaier and A Haverich. (2002). Transplanted fetal cardiomyocytes as cardiac pacemaker. Eur J Cardiothorac Surg 21:853-857.
158. Chiu RC, A Zibaitis and RL Kao. (1995). Cellular cardiomyo-plasty: myocardial regeneration with satellite cell implantation. Ann Thorac Surg 60:12-18.
159. Murry CE, RW Wiseman, SM Schwartz and SD Hauschka. (1996). Skeletal myoblast transplantation for repair of myocar-dial necrosis. J Clin Invest 98:2512-2523.
160. Menasche P, AA Hagege, M Scorsin, B Pouzet, M Desnos, D Duboc, K Schwartz, JT Vilquin and JP Marolleau. (2001). Myoblast transplantation for heart failure. Lancet 357: 279-280.
161. Menasche P, AA Hagege, JT Vilquin, M Desnos, E Abergel, B Pouzet, A Bel, S Sarateanu, M Scorsin, K Schwartz, P Bruneval, M Benbunan, JP Marolleau and D Duboc. (2003). Autologous skeletal myoblast transplantation for severe postinfarction left ventricular dysfunction. J Am Coll Cardiol 41:1078-1083.
162. Hagege AA, JP Marolleau, JT Vilquin, A Alheritiere, S Peyrard, D Duboc, E Abergel, E Messas, E Mousseaux, K Schwartz, M Desnos and P Menasche. (2006). Skeletal myoblast transplantation in ischemic heart failure: long-term follow-up of the f rst phase I cohort of patients. Circulation 114:I108-I113.
163. Murry CE, ML Whitney, MA Laf amme, H Reinecke and LJ Field. (2002). Cellular therapies for myocardial infarct repair. Cold Spring Harb Symp Quant Biol 67:519-526.
164. Herreros J, F Prosper, A Perez, JJ Gavira, MJ Garcia-Velloso, J Barba, PL Sanchez, C Canizo, G Rabago, JM Marti-Climent, M Hernandez, N Lopez-Holgado, JM Gonzalez-Santos, C Martin-Luengo and E Alegria. (2003). Autologous intramyo-cardial injection of cultured skeletal muscle-derived stem cells in patients with non-acute myocardial infarction. Eur Heart J 24:2012-2020.
165. Siminiak T, R Kalawski, D Fiszer, O Jerzykowska, J Rzezniczak, N Rozwadowska and M Kurpisz. (2004). Autologous skeletal myoblast transplantation for the treatment of postinfarction myocardial injury: phase I clinical study with 12 months of follow-up. Am Heart J 148:531-537.
166. Gavira JJ, J Herreros, A Perez, MJ Garcia-Velloso, J Barba, F Martin-Herrero, C Canizo, A Martin-Arnau, JM Marti-Climent, M Hernandez, N Lopez-Holgado, JM Gonzalez-Santos, C Martin-Luengo, E Alegria and F Prosper. (2006). Autologous skeletal myoblast transplantation in patients with nonacute myocardial infarction: 1-year follow-up. J Thorac Cardiovasc Surg 131:799-804.
167. Dib N, RE Michler, FD Pagani, S Wright, DJ Kereiakes, R Lengerich, P Binkley, D Buchele, I Anand, C Swingen, MF Di Carli, JD Thomas, WA Jaber, SR Opie, A Campbell, P McCarthy, M Yeager, V Dilsizian, BP Griff th, R Korn, SK Kreuger, M Ghazoul, WR MacLellan, G Fonarow, HJ Eisen, J Dinsmore and E Diethrich. (2005). Safety and feasibility of autologous myo-blast transplantation in patients with ischemic cardiomyopa-thy: four-year follow-up. Circulation 112:1748-1755.
168. Menasche P, M Desnos and AA Hagege. (2006). Routine delivery of myoblasts during coronary artery bypass surgery: why not? Nat Clin Pract Cardiovasc Med 3(Suppl 1):S90-S93.
169. Roell W, T Lewalter, P Sasse, YN Tallini, BR Choi, M Breitbach, R Doran, UM Becher, SM Hwang, T Bostani, J von Maltzahn, A Hofmann, S Reining, B Eiberger, B Gabris, A Pfeifer, A Welz, K Willecke, G Salama, JW Schrickel, MI Kotlikoff and BK Fleischmann. (2007). Engraftment of connexin 43-expressing cells prevents post-infarct arrhythmia. Nature 450:819-824.
170. Reinecke H, V Poppa and CE Murry. (2002). Skeletal muscle stem cells do not transdifferentiate into cardiomyocytes after cardiac grafting. J Mol Cell Cardiol 34:241-249.
171. Oshima H, TR Payne, KL Urish, T Sakai, Y Ling, B Gharaibeh, K Tobita, BB Keller, JH Cummins and J Huard. (2005). Differential myocardial infarct repair with muscle stem cells compared to myoblasts. Mol Ther 12:1130-1141.
172. Hammond HK. (2007). Skeletal muscle-derived stem cell transplantation: angiogenesis is required for improved left ventricular function. J Am Coll Cardiol 50:1685-1687.
173. Payne TR, H Oshima, M Okada, N Momoi, K Tobita, BB Keller, H Peng and J Huard. (2007). A relationship between vascular endothelial growth factor, angiogenesis, and cardiac repair after muscle stem cell transplantation into ischemic hearts. J Am Coll Cardiol 50:1677-1684.
174. Most P, ST Pleger, M Volkers, B Heidt, M Boerries, D Weichenhan, E Loff er, PM Janssen, AD Eckhart, J Martini, ML Williams, HA Katus, A Remppis and WJ Koch. (2004). Cardiac adenoviral S100A1 gene delivery rescues failing myocardium. J Clin Invest 114:1550-1563.
175. Teng G, X Zhao, JC Cross, P Li, JP Lees-Miller, J Guo, JR Dyck and HJ Duff. (2004). Prolonged repolarization and triggered activity induced by adenoviral expression of HERG N629D in cardiomyocytes derived from stem cells. Cardiovasc Res 61:268-277.
176. Etzion S, LH Kedes, RA Kloner and J Leor. (2001). Myocardial regeneration: present and future trends. Am J Cardiovasc Drugs 1:233-244.
177. Murry CE, MA Kay, T Bartosek, SD Hauschka and SM Schwartz. (1996). Muscle differentiation during repair of myo-cardial necrosis in rats via gene transfer with MyoD. J Clin Invest 98:2209-2217.
178. Retuerto MA, P Schalch, G Patejunas, J Carbray, N Liu, K Esser, RG Crystal and TK Rosengart. (2004). Angiogenic pretreatment improves the eff cacy of cellular cardiomyoplasty performed with fetal cardiomyocyte implantation. J Thorac Cardiovasc Surg 127:1041-1049; discussion 1049-1051.
179. Suzuki K, B Murtuza, RT Smolenski, IA Sammut, N Suzuki, Y Kaneda and MH Yacoub. (2001). Cell transplantation for the treatment of acute myocardial infarction using vascular endothelial growth factor-expressing skeletal myoblasts. Circulation 104:I207-I212.
180. Rideout WM, III, K Hochedlinger, M Kyba, GQ Daley and R Jaenisch. (2002). Correction of a genetic defect by nuclear transplantation and combined cell and gene therapy. Cell 109:17-27.
181. Takahashi K and S Yamanaka. (2006). Induction of pluripotent stem cells from mouse embryonic and adult f broblast cultures by def ned factors. Cell 126:663-676.
182. Yu J, MA Vodyanik, K Smuga-Otto, J Antosiewicz-Bourget, JL Frane, S Tian, J Nie, GA Jonsdottir, V Ruotti, R Stewart, Slukvin, II and JA Thomson. (2007). Induced pluripotent stem cell lines derived from human somatic cells. Science 318:1917-1920.
183. Okita K, T Ichisaka and S Yamanaka. (2007). Generation of germline-competent induced pluripotent stem cells. Nature 448:313-317.
184. Maherali N and K Hochedlinger. (2008). Induced Pluripotency of Mouse and Human Somatic Cells. Cold Spring Harb Symp Quant Biol. [Epub Ahead of print]
185. Maherali N and K Hochedlinger. (2008). Guidelines and techniques for the generation of induced pluripotent stem cells. Cell Stem Cell 3:595-605.
186. Maherali N, R Sridharan, W Xie, J Utikal, S Eminli, K Arnold, M Stadtfeld, R Yachechko, J Tchieu, R Jaenisch, K Plath and K Hochedlinger. (2007). Directly reprogrammed f broblasts show global epigenetic remodeling and widespread tissue contribution. Cell Stem Cell 1:55-70.
187. Park IH, PH Lerou, R Zhao, H Huo and GQ Daley. (2008). Generation of human-induced pluripotent stem cells. Nat Protoc 3:1180-1186.
188. Park IH, R Zhao, JA West, A Yabuuchi, H Huo, TA Ince, PH Lerou, MW Lensch and GQ Daley. (2008). Reprogramming of human somatic cells to pluripotency with def ned factors. Nature 451:141-146.
189. Mauritz C, K Schwanke, M Reppel, S Neef, K Katsirntaki, LS Maier, F Nguemo, S Menke, M Haustein, J Hescheler, G Hasenfuss and U Martin. (2008). Generation of functional murine cardiac myocytes from induced pluripotent stem cells. Circulation 118:507-517.
190. Fodor WL. (2003). Tissue engineering and cell based therapies, from the bench to the clinic: the potential to replace, repair and regenerate. Reprod Biol Endocrinol 1:102.
191. Langer R. (2000). Biomateri als i n drug deliver y and t issue engineering: one laboratory's experience. Acc Chem Res 33:94-101.
192. Wright VJ, H Peng and J Huard. (2001). Muscle-based gene therapy and tissue engineering for the musculoskeletal system. Drug Discov Today 6:728-733.
193. Caspi O, A Lesman, Y Basevitch, A Gepstein, G Arbel, IH Habib, L Gepstein and S Levenberg. (2007). Tissue engineering of vascularized cardiac muscle from human embryonic stem cells. Circ Res 100:263-272.